Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19


Game-changing restraint of Ros-damaged phenylalanine, upon tumor metastasis.

Gueron G, Anselmino N, Chiarella P, Ortiz EG, Lage Vickers S, Paez AV, Giudice J, Contin MD, Leonardi D, Jaworski F, Manzano V, Strazza A, Montagna DR, Labanca E, Cotignola J, D Accorso N, Woloszynska-Read A, Navone N, Meiss RP, Ruggiero R, Vazquez E.

Cell Death Dis. 2018 Feb 2;9(2):140. doi: 10.1038/s41419-017-0147-8.


Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer.

Ramakrishnan S, Hu Q, Krishnan N, Wang D, Smit E, Granger V, Rak M, Attwood K, Johnson C, Morrison C, Pili R, Chatta G, Guru K, Gueron G, McNally L, Wang J, Woloszynska-Read A.

Cell Death Dis. 2017 Dec 14;8(12):3217. doi: 10.1038/s41419-017-0024-5.


In Vivo Hemin Conditioning Targets the Vascular and Immunologic Compartments and Restrains Prostate Tumor Development.

Jaworski FM, Gentilini LD, Gueron G, Meiss RP, Ortiz EG, Berguer PM, Ahmed A, Navone N, Rabinovich GA, Compagno D, Laderach DJ, Vazquez ES.

Clin Cancer Res. 2017 Sep 1;23(17):5135-5148. doi: 10.1158/1078-0432.CCR-17-0112. Epub 2017 May 16.


Heme oxygenase 1 governs the cytoskeleton at filopodia: pulling the brakes on the migratory capacity of prostate tumoral cells.

Paez A, Vazquez E, Gueron G.

Cell Death Discov. 2017 Apr 3;3:17020. doi: 10.1038/cddiscovery.2017.20. eCollection 2017. No abstract available.


Heme oxygenase-1 in the forefront of a multi-molecular network that governs cell-cell contacts and filopodia-induced zippering in prostate cancer.

Paez AV, Pallavicini C, Schuster F, Valacco MP, Giudice J, Ortiz EG, Anselmino N, Labanca E, Binaghi M, Salierno M, Martí MA, Cotignola JH, Woloszynska-Read A, Bruno L, Levi V, Navone N, Vazquez ES, Gueron G.

Cell Death Dis. 2016 Dec 29;7(12):e2570. doi: 10.1038/cddis.2016.420.


Improving risk stratification of patients with childhood acute lymphoblastic leukemia: Glutathione-S-Transferases polymorphisms are associated with increased risk of relapse.

Leonardi DB, Abbate M, Riccheri MC, Nuñez M, Alfonso G, Gueron G, De Siervi A, Vazquez E, Cotignola J.

Oncotarget. 2017 Jan 3;8(1):110-117. doi: 10.18632/oncotarget.8606.


Association of HO-1 and BRCA1 Is Critical for the Maintenance of Cellular Homeostasis in Prostate Cancer.

Labanca E, De Luca P, Gueron G, Paez A, Moiola CP, Massillo C, Porretti J, Giudice J, Zalazar F, Navone N, Vazquez E, De Siervi A.

Mol Cancer Res. 2015 Nov;13(11):1455-64. doi: 10.1158/1541-7786.MCR-15-0150-T. Epub 2015 Jul 30.


Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation.

Ahmad S, Hewett PW, Fujisawa T, Sissaoui S, Cai M, Gueron G, Al-Ani B, Cudmore M, Ahmed SF, Wong MK, Wegiel B, Otterbein LE, Vítek L, Ramma W, Wang K, Ahmed A.

Thromb Haemost. 2015 Feb;113(2):329-37. doi: 10.1160/TH14-01-0002. Epub 2014 Oct 30.


Differential effect of heterocyclic D-ribofuranoside derivatives on human prostate cancer cell viability and cell cycle progression.

Gueron G, Avanzo RE, Schuster F, Carabelos MN, Vazquez E, Fascio ML, D'Accorso NB.

Biomed Pharmacother. 2014 Sep;68(7):847-54. doi: 10.1016/j.biopha.2014.08.010. Epub 2014 Aug 19.


Heme-oxygenase-1 implications in cell morphology and the adhesive behavior of prostate cancer cells.

Gueron G, Giudice J, Valacco P, Paez A, Elguero B, Toscani M, Jaworski F, Leskow FC, Cotignola J, Marti M, Binaghi M, Navone N, Vazquez E.

Oncotarget. 2014 Jun 30;5(12):4087-102.


Unveiling the association of STAT3 and HO-1 in prostate cancer: role beyond heme degradation.

Elguero B, Gueron G, Giudice J, Toscani MA, De Luca P, Zalazar F, Coluccio-Leskow F, Meiss R, Navone N, De Siervi A, Vazquez E.

Neoplasia. 2012 Nov;14(11):1043-56.


Advanced prostate cancer: reinforcing the strings between inflammation and the metastatic behavior.

Gueron G, De Siervi A, Vazquez E.

Prostate Cancer Prostatic Dis. 2012 Sep;15(3):213-21. doi: 10.1038/pcan.2011.64. Epub 2011 Dec 20. Review.


Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer.

Ferrando M, Gueron G, Elguero B, Giudice J, Salles A, Leskow FC, Jares-Erijman EA, Colombo L, Meiss R, Navone N, De Siervi A, Vazquez E.

Angiogenesis. 2011 Dec;14(4):467-79. doi: 10.1007/s10456-011-9230-4. Epub 2011 Aug 11.


BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer.

De Luca P, Vazquez ES, Moiola CP, Zalazar F, Cotignola J, Gueron G, Gardner K, De Siervi A.

Mol Cancer Res. 2011 Aug;9(8):1078-90. doi: 10.1158/1541-7786.MCR-11-0155. Epub 2011 Jun 23.


Key questions in metastasis: new insights in molecular pathways and therapeutic implications.

Gueron G, De Siervi A, Vazquez E.

Curr Pharm Biotechnol. 2011 Nov;12(11):1867-80. Review.


Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells.

Gueron G, De Siervi A, Ferrando M, Salierno M, De Luca P, Elguero B, Meiss R, Navone N, Vazquez ES.

Mol Cancer Res. 2009 Nov;7(11):1745-55. doi: 10.1158/1541-7786.MCR-08-0325. Epub 2009 Nov 10.


Identification of new Rel/NFkappaB regulatory networks by focused genome location analysis.

De Siervi A, De Luca P, Moiola C, Gueron G, Tongbai R, Chandramouli GV, Haggerty C, Dzekunova I, Petersen D, Kawasaki E, Kil WJ, Camphausen K, Longo D, Gardner K.

Cell Cycle. 2009 Jul 1;8(13):2093-100. Epub 2009 Jul 5.


Combinatorial antileukemic disruption of oxidative homeostasis and mitochondrial stability by the redox reactive thalidomide 2-(2,4-difluoro-phenyl)-4,5,6,7-tetrafluoro-1H-isoindole-1,3(2H)-dione (CPS49) and flavopiridol.

Ge Y, Byun JS, De Luca P, Gueron G, Yabe IM, Sadiq-Ali SG, Figg WD, Quintero J, Haggerty CM, Li QQ, De Siervi A, Gardner K.

Mol Pharmacol. 2008 Sep;74(3):872-83. doi: 10.1124/mol.107.040808. Epub 2008 Jun 12.


[Acute bone marrow insufficiency subsequent to infection or administration of pyramidon].


Harefuah. 1957 May 15;52(10):260. Hebrew. No abstract available.


Supplemental Content

Loading ...
Support Center